Analysis of influencing factors on schizophrenia patients with sequential therapy of ziprasidone

Jia XU,Yue LI,Chun-feng FU,Chun-yan YU,Cong-pei ZHANG

DOI: https://doi.org/10.11886/j.issn.1007-3256.2016.02.015

2016-01-01

Abstract:Objective To observe curative effect of applying sequential therapy of oral dosage forms after the aiprasidone mesylate injection treatment for people with schiaophreniaand and analysis the influencing factors for providing clinical basis in reasonable application of sequential treatment. Methods Totally 40 patients with schiaophrenia according to the Diagnostic and Statistical Manual of Mental Disorders Fourth edition(DSM - IV)who mainly showed symptoms of excitation and agitation were evaluated using Positive and Negative Syndrome Scale(PANSS). General situation questionnaire was used to investigate patients before treatment(baseline).After 72 hours of aiprasidone mesylate injection treatment,sequential therapy was conducted with oral aiprasidone. Patients were assess ed using PANSS at baseline and 72 hours after treatment of intramuscular injection. Side effects were assessed with Treatment Emergent Symptom Scale(TESS). Results 24 patients were succeeded in the sequential treatment. There were 16 patients whose therapeutic effect were poor because of the efficacy and tolerance of treatment,in which 7 patients’treatment were changed with another second generation of atypical antipsychotics. Second sequential therapy were applied to another 9 patients after 3 days therapy of aiprasidone mesylate for injection,in which 5 patients were succeeded and 4 patients’treatments were replaced with another second generation of atypical antipsychotics. Conclusion The second injection treatment can be applied to the patients who were not succeed in the first sequential therapy and some patients were succeeded in the second sequential therapy. The efficacy of sequential therapy is associated with patients’weight,drinking habits and whether first - episode. It is also related to other factor except injection factors,such as the relationship between patients and doctors,quality of the therapeutic alliance.